Oncology Drugs Market Research Report, Growth & Forecast

HNY Research projects that the Hepatocellular Carcinoma Targeted Drug market size will grow from 987.75 Million USD in 2025 to 1659.05 Million USD by 2031, at an estimated CAGR of 9.03%. The base year...

HNY Research projects that the Castrate Resistant Prostate Cancer Therapeutics market size will grow from 19063.2 Million USD in 2025 to 39875.06 Million USD by 2031, at an estimated CAGR of 13.09%. T...

According to our (Global Info Research) latest study, the global Combination Therapies for Melanoma market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by...

According to our (Global Info Research) latest study, the global Sacituzumab Tirumotecan market size was valued at US$ 206 million in 2025 and is forecast to a readjusted size of US$ 936 million by 20...

HNY Research projects that the Anti-HER2 Therapy market size will grow from 6258.56 Million USD in 2025 to 8446.15 Million USD by 2031, at an estimated CAGR of 5.12%. The base year considered for the...

HNY Research projects that the Targeted Therapy for Brain Cancer market size will grow from 1512.75 Million USD in 2025 to 2766.19 Million USD by 2031, at an estimated CAGR of 10.58%. The base year co...

HNY Research projects that the Kidney Cancer Therapeutics market size will grow from 457.42 Million USD in 2025 to 594.95 Million USD by 2031, at an estimated CAGR of 4.48%. The base year considered f...

HNY Research projects that the Anticancer Drugs market size will grow from 210.21 Million USD in 2025 to 437.43 Million USD by 2031, at an estimated CAGR of 12.99%. The base year considered for the st...

HNY Research projects that the Non-muscle Invasive Bladder Cancer Therapeutics market size will grow from 3772.41 Million USD in 2025 to 5848.77 Million USD by 2031, at an estimated CAGR of 7.58%. The...

HNY Research projects that the Sarcoma Drugs market size will grow from 1018.02 Million USD in 2025 to 1467.84 Million USD by 2031, at an estimated CAGR of 6.29%. The base year considered for the stud...

HNY Research projects that the Sezary Syndrome Treatment market size will grow from 796.08 Million USD in 2025 to 1348.62 Million USD by 2031, at an estimated CAGR of 9.18%. The base year considered f...

HNY Research projects that the Vinca Alkaloid Compounds market size will grow from 114.13 Million USD in 2025 to 181.98 Million USD by 2031, at an estimated CAGR of 8.09%. The base year considered for...

HNY Research projects that the Capecitabine market size will grow from 1028.18 Million USD in 2025 to 1362.19 Million USD by 2031, at an estimated CAGR of 4.8%. The base year considered for the study...

HNY Research projects that the Oxaliplatin market size will grow from 1084.26 Million USD in 2025 to 1953.3 Million USD by 2031, at an estimated CAGR of 10.31%. The base year considered for the study...

HNY Research projects that the Platinum based Cancer Drug market size will grow from 1643.89 Million USD in 2025 to 1993.08 Million USD by 2031, at an estimated CAGR of 3.26%. The base year considered...

Report Findings & Highlights: Currently Only 1 Vaccine Approved In Market: ProvengeNext Commercial Approval Expected By 2031 For NSCL/MelanomaPricing & Dosing Insight On Only Approved Personalized Ca...

Report Findings & Highlights: First CD70 Targeted Therapy Approval Anticipated By 2032Current Highest Phase Of Development: Phase-IIInsight On CD70 Targeting Therapies In Clinical Trials: > 30 Therap...

Report Findings & Highlights: First KIF18A Targeting Therapy Commercial Availability Expected By 2032Highest Phase Of Clinical Trials: Phase-I/IIInsight On KIF18A Targeting Therapies In Clinical Tria...

The global SmFeN Magnetic Compounds market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for S...

The global HER2 Inhibitors market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for HER2 Inhib...

The global Poly (ADP-Ribose) Polymerase (PARP) Inhibitors market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Unit...

The global Targeted Therapy Drugs for Leukemia market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Leukemia is a m...

The global Medical Marijuana Market size is forecast to increase from $20.15 Billion in 2026 to $86.3 Billion in 2034 at a CAGR of 19.94% between 2026 and 2034. The Medical Marijuana market report pro...

The global Interventional Oncology Devices Market size is forecast to increase from $3.13 Billion in 2026 to $6.01 Billion in 2034 at a CAGR of 8.5% between 2026 and 2034. The Interventional Oncology...

The global Intraoperative Radiation Therapy Market size is forecast to increase from $72.6 Million in 2026 to $118.36 Million in 2034 at a CAGR of 6.3% between 2026 and 2034. The Intraoperative Radiat...

The global Kaposi Sarcoma Market size is forecast to increase from $147.02 Million in 2026 to $205.27 Million in 2034 at a CAGR of 4.26% between 2026 and 2034. The Kaposi Sarcoma market report provide...

The global Leukemia Therapeutics Market size is forecast to increase from $20.1 Billion in 2026 to $33.77 Billion in 2034 at a CAGR of 6.7% between 2026 and 2034. The Leukemia Therapeutics market repo...

The global Lung Cancer Surgery Market size is forecast to increase from $6.14 Billion in 2026 to $8.53 Billion in 2034 at a CAGR of 4.2% between 2026 and 2034. The Lung Cancer Surgery market report pr...

The global Lung Cancer Therapeutics Market size is forecast to increase from $30.61 Billion in 2026 to $59.22 Billion in 2034 at a CAGR of 8.6% between 2026 and 2034. The Lung Cancer Therapeutics mark...

The global Melanoma Diagnostics and Therapeutics Market size is forecast to increase from $9.01 Billion in 2026 to $19.88 Billion in 2034 at a CAGR of 10.4% between 2026 and 2034. The Melanoma Diagnos...

The global Nasopharyngeal Cancer Market size is forecast to increase from $1.28 Billion in 2026 to $2.18 Billion in 2034 at a CAGR of 6.9% between 2026 and 2034. The Nasopharyngeal Cancer market repor...

The global Neuroendocrine Tumor Treatment Market size is forecast to increase from $2.9 Billion in 2026 to $4.67 Billion in 2034 at a CAGR of 6.13% between 2026 and 2034. The Neuroendocrine Tumor Trea...

The global NTRK Fusion Gene Positive Advanced Solid Tumor Market size is forecast to increase from $454.02 Million in 2026 to $640.74 Million in 2034 at a CAGR of 4.4% between 2026 and 2034. The NTRK...

The global Pancreatic Cancer Therapeutics and Diagnostics Market size is forecast to increase from $5.49 Billion in 2026 to $9.69 Billion in 2034 at a CAGR of 7.36% between 2026 and 2034. The Pancreat...

The global Particle Therapy Market size is forecast to increase from $1.92 Billion in 2026 to $3.35 Billion in 2034 at a CAGR of 7.2% between 2026 and 2034. The Particle Therapy market report provides...

The global Pediatric Neuroblastoma Treatment Market size is forecast to increase from $2.5 Billion in 2026 to $5.05 Billion in 2034 at a CAGR of 9.2% between 2026 and 2034. The Pediatric Neuroblastoma...

The global Prostate Cancer Diagnostics and Therapy Market size is forecast to increase from $15.37 Billion in 2026 to $29.96 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034. The Prostate Cance...

The global Radiotherapy Market size is forecast to increase from $9.3 Billion in 2026 to $13.43 Billion in 2034 at a CAGR of 4.7% between 2026 and 2034. The Radiotherapy market report provides detaile...

The global Retinoblastoma Treatment Market size is forecast to increase from $2.96 Billion in 2026 to $4.25 Billion in 2034 at a CAGR of 4.63% between 2026 and 2034. The Retinoblastoma Treatment marke...

The global Skin Antiseptic Products Market size is forecast to increase from $7.96 Billion in 2026 to $13.89 Billion in 2034 at a CAGR of 7.21% between 2026 and 2034. The Skin Antiseptic Products mark...

The global Stereotactic Radiosurgery (Gamma Knife) Market size is forecast to increase from $471.42 Million in 2026 to $757.06 Million in 2034 at a CAGR of 6.1% between 2026 and 2034. The Stereotactic...

The global T-cell Acute Lymphoblastic Leukemia Treatment Market size is forecast to increase from $3.3 Billion in 2026 to $5.59 Billion in 2034 at a CAGR of 6.8% between 2026 and 2034. The T-cell Acut...

The global T-cell lymphoma Market size is forecast to increase from $2.81 Billion in 2026 to $5.36 Billion in 2034 at a CAGR of 8.4% between 2026 and 2034. The T-cell lymphoma market report provides d...

The global Thyroid Cancer Therapeutics Market size is forecast to increase from $1026.69 Million in 2026 to $3206.81 Million in 2034 at a CAGR of 15.3% between 2026 and 2034. The Thyroid Cancer Therap...

The global Tumor Ablation Market size is forecast to increase from $2.5 Billion in 2026 to $7.39 Billion in 2034 at a CAGR of 14.5% between 2026 and 2034. The Tumor Ablation market report provides det...

The global Tumor Tracking Systems Market size is forecast to increase from $4.9 Billion in 2026 to $7.16 Billion in 2034 at a CAGR of 4.85% between 2026 and 2034. The Tumor Tracking Systems market rep...

The global Tyrosine Kinase Inhibitors Market size is forecast to increase from $66.29 Billion in 2026 to $124.53 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034. The Tyrosine Kinase Inhibitors...

The global Unresectable Hepatocellular Carcinoma Market size is forecast to increase from $2.58 Billion in 2026 to $4.81 Billion in 2034 at a CAGR of 8.1% between 2026 and 2034. The Unresectable Hepat...

The global Kidney Cancer Drugs Market size is forecast to increase from $7.35 Billion in 2026 to $12.44 Billion in 2034 at a CAGR of 6.8% between 2026 and 2034. The Kidney Cancer Drugs market report p...

The global Lenalidomide Market size is forecast to increase from $15.57 Billion in 2026 to $23.88 Billion in 2034 at a CAGR of 5.49% between 2026 and 2034. The Lenalidomide market report provides deta...